DE69115539D1 - Immunologische Komponente, Verfahren zur Synthese und Verwendung in Anit-Malaria-Impfstoff-Zusammensetzungen - Google Patents

Immunologische Komponente, Verfahren zur Synthese und Verwendung in Anit-Malaria-Impfstoff-Zusammensetzungen

Info

Publication number
DE69115539D1
DE69115539D1 DE69115539T DE69115539T DE69115539D1 DE 69115539 D1 DE69115539 D1 DE 69115539D1 DE 69115539 T DE69115539 T DE 69115539T DE 69115539 T DE69115539 T DE 69115539T DE 69115539 D1 DE69115539 D1 DE 69115539D1
Authority
DE
Germany
Prior art keywords
amino acid
lysine
acid residue
chem
direct bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69115539T
Other languages
English (en)
Other versions
DE69115539T2 (de
Inventor
Antonello Pessi
Elisabetta Bianchi
Giampietro Corradin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eni Tecnologie SpA
Original Assignee
Eniricerche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche SpA filed Critical Eniricerche SpA
Publication of DE69115539D1 publication Critical patent/DE69115539D1/de
Application granted granted Critical
Publication of DE69115539T2 publication Critical patent/DE69115539T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69115539T 1990-04-02 1991-03-28 Immunologische Komponente, Verfahren zur Synthese und Verwendung in Anit-Malaria-Impfstoff-Zusammensetzungen Expired - Fee Related DE69115539T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19914A IT1241395B (it) 1990-04-02 1990-04-02 Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria

Publications (2)

Publication Number Publication Date
DE69115539D1 true DE69115539D1 (de) 1996-02-01
DE69115539T2 DE69115539T2 (de) 1996-08-01

Family

ID=11162291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69115539T Expired - Fee Related DE69115539T2 (de) 1990-04-02 1991-03-28 Immunologische Komponente, Verfahren zur Synthese und Verwendung in Anit-Malaria-Impfstoff-Zusammensetzungen

Country Status (7)

Country Link
EP (1) EP0450715B1 (de)
AT (1) ATE131830T1 (de)
DE (1) DE69115539T2 (de)
DK (1) DK0450715T3 (de)
ES (1) ES2082109T3 (de)
GR (1) GR3018750T3 (de)
IT (1) IT1241395B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107434D0 (en) * 1991-04-09 1991-05-22 Medical Res Council Peptide-based assay
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
MXPA05003057A (es) 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
CN102241742B (zh) 2003-08-28 2014-04-02 奥索-麦克尼尔药品公司 结合血小板生成素受体的肽和化合物
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
CN102153654B (zh) * 2009-12-31 2012-10-10 中国疾病预防控制中心病毒病预防控制所 以免疫活性肽为载体的分支多肽及其衍生物与应用
SG11201506804VA (en) 2013-03-21 2015-09-29 Sanofi Aventis Deutschland Synthesis of hydantoin containing peptide products
WO2014147129A1 (en) 2013-03-21 2014-09-25 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
US10583184B2 (en) 2014-11-28 2020-03-10 Shigeyuki Kano Artificial antigen produced using partial sequence of enolase protein originated from plasmodium falciparum, and method for producing same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
ES2052517T3 (es) * 1986-07-16 1994-07-16 Eniricerche Spa Analogos de tuftsina parcialmente retroinversos, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.
IT1216908B (it) * 1987-03-19 1990-03-14 Eniricerche Spa Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
EP0378881B1 (de) * 1989-01-17 1993-06-09 ENIRICERCHE S.p.A. Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind
CA2031197A1 (en) * 1989-04-12 1990-10-13 James P. Tam Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine

Also Published As

Publication number Publication date
IT9019914A1 (it) 1991-10-02
DK0450715T3 (da) 1996-02-26
DE69115539T2 (de) 1996-08-01
EP0450715B1 (de) 1995-12-20
ES2082109T3 (es) 1996-03-16
IT1241395B (it) 1994-01-10
EP0450715A1 (de) 1991-10-09
GR3018750T3 (en) 1996-04-30
IT9019914A0 (it) 1990-04-02
ATE131830T1 (de) 1996-01-15

Similar Documents

Publication Publication Date Title
DE69115539D1 (de) Immunologische Komponente, Verfahren zur Synthese und Verwendung in Anit-Malaria-Impfstoff-Zusammensetzungen
EP0409607B1 (de) Antikörper gegen menschlichen Interleukin-6-Rezeptor
CA2554195A1 (en) Peptide originating in epidermal growth factor receptor (egfr)
EP3805248A3 (de) Prozess, um antikörper und therapeutische produkte zu konzentrieren
DE3484691D1 (de) Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
JP2013009682A5 (de)
KR860004081A (ko) 폴리펩티드의 제조방법
US20210315992A1 (en) Adjuvant effect of the tlr1/2 agonist diprovocim synergizes with checkpoint-inhibiting antibodies to eliminate disease
CY1111431T1 (el) Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων
CA3127098A1 (en) Glycoside-containing peptide linkers for antibody-drug conjugates
CA3019398A1 (en) Antibody conjugates and methods of making and using the same
Ramasamy et al. Characterisation of an inhibitory monoclonal antibody-defined epitope on a malaria vaccine candidate antigen
CA2003211A1 (en) Monoclonal antibodies
ATE126236T1 (de) Protein-derivate und verfahren zu ihrer herstellung.
DE69014150D1 (de) Immunogen-Verbindungen und deren Benutzung in der Herstellung von genetisch unbeschränkten synthetischen Impfstoffen und bei der immunoenzymatischer Bestimmung von antisporozoiden Antikörpern von Plasmodium malariae.
WO2018169953A1 (en) Antibody conjugates and methods of making and using the same
ATE119202T1 (de) Verfahren zur herstellung von l-aminosäuren und aminosäure-amiden.
IT1241081B (it) Composti immunogenici e loro impiego per la preparazione di vaccini sintetici geneticamente non ristretti per la determinazione immunoenzimatica di anticorpi anti-sporozoita di plasmodium malariae
JP2009528282A5 (de)
Mozes et al. The genetic control of the immune response to different antigenic determinants within the synthetic polypeptide poly (His, Glu)‐polyPro–poly Lys
CA2067124A1 (en) Cationized carriers for immunogen production
US6639075B2 (en) Lactam-aldehyde compound and process of preparing same
WO2023212650A1 (en) Next generation diprovocims that activate the innate and adaptive immune response
EP0088752B1 (de) Antigen-peptidverbindung
Guzman et al. In vitro immunization with antigen directly blotted from SDS-polyacrylamide gels to polyvinylidene difluoride membranes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee